Skip to main content

Table 3 Statistical significance of serum urea, creatinine, and uric acid in the studied groups

From: Insulin receptor substrate-1 G972R single nucleotide polymorphism in Egyptian patients with chronic hepatitis C virus infection and type 2 diabetes mellitus

Parameters

Group I (n = 50)

Group II (n = 50)

Group III (n = 52)

Group IV (n = 50)

Test of sig.

P

Urea (mg/dl)

 Min.–Max.

12.0–40.0

20.0–99.0

11.0–250.0

14.0–242.0

H = 41.355

< 0.001*

 Mean ± SD.

26.32 ± 7.05

40.82 ± 20.38

47.58 ± 44.06

59.56 ± 43.55

 Median

26.0

34.0

35.0

45.0

 PGroup I

 

< 0.001*

< 0.001*

< 0.001*

  

 Sig. bet. Groups

 

P1 = 0.829, P2 = 0.028*, P3 = 0.045*

  

Creatinine (mg/dl)

 Min.–Max.

0.60–1.10

0.70–2.10

0.60–4.80

0.60–2.50

H = 50.629

< 0.001*

 Mean ± SD.

0.81 ± .15

1.08 ± 0.38

1.25 ± 0.64

1.21 ± 0.42

 Median

0.80

0 .90

1.10

1.15

 PGroup I

 

< 0.001*

< 0.001*

< 0.001*

  

 Sig. bet. Groups

 

P1 = 0.031*, P2 = 0.031*, P3 = 0.983

  

Uric acid (mg/dl)

 Min.–Max.

2.90–5.80

3.80–10.0

2.10–6.70

3.50–9.30

F = 44.584

<0.001*

 Mean ± SD.

4.33 ± .76

6.72 ± 1.74

4.17 ± 1.01

5.67 ± 1.40

 Median

4.30

6.50

4.10

5.30

 PGroup I

 

< 0.001*

0.916

< 0.001*

  

 Sig. bet. Groups

 

P1 < 0.001*, P2 < 0.001*, P3 < 0.001*

  
  1. F, F for ANOVA test, pairwise comparison bet. each 2 groups was done using post hoc test (Tukey); H, H for Kruskal–Wallis test, pairwise comparison bet. each 2 groups was done using post hoc test (Dunn’s for multiple comparisons test); P, P value for comparing between the different groups; PGroup I, P value for comparing between group I and each other groups; P1, P value for comparing between group II and group III; P2, P value for comparing between group II and group IV; P3, P value for comparing between group III and group IV; Sig. bet. Groups, significance between groups
  2. *Statistically significant at P ≤ 0.05